The US Food and Drug Administration (FDA) is proposing a new rule that would apply its regulations on prescription fixed-combination drugs to a variety of nonprescription fixed-combination and ...
Navigating FDA's rules to get a fixed-dose combination therapy for chronic obstructive pulmonary disease approved required a large study and a specific population. When GlaxoSmithKline designed the ...
The US Food and Drug Administration's (FDA) Office of Combination Products (OCP) has released a new final regulation on the current good manufacturing practices (cGMPs) used in the manufacture of ...
The office put out a draft guidance in 2004 about how these should be integrated for combination products, but has not issued any further official word.Nguyen implied that the proposed rule on GMPs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results